How Many Injections of Ozempic to Lose Weight: A Comprehensive Guide

Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections represent a clinically proven approach to weight management, with trials showing an average weight loss of 15% over 68 weeks at therapeutic doses. The medication works by slowing stomach emptying and signaling fullness to your brain, reducing hunger and calorie intake naturally. Understanding how dosing works—and what to expect at each stage—helps you make informed decisions about starting treatment.

How Semaglutide Injection Dosing Works for Weight Loss

Semaglutide injections follow a titration schedule, meaning your starting dose is intentionally low and increases gradually every four weeks. Most treatment plans begin at 0.25 mg weekly, then step up to 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg at the maintenance phase. This gradual approach allows your body to adapt while minimizing side effects like nausea and helps your healthcare provider find your optimal therapeutic dose.

The entire titration process typically takes 16 to 20 weeks to reach the full maintenance dose. During this time, you'll inject yourself once per week on the same day, using a simple prefilled pen that stores in your refrigerator. Each injection takes less than ten seconds, and most patients report that the needle is barely noticeable due to its thin gauge and short length.

Weekly Injection Schedule and Timeline for Results

Your first injection begins the weight loss journey, though most noticeable changes appear between weeks 4 and 8 as your dose reaches 0.5 mg and your appetite suppression increases. Meaningful weight loss—typically 5 to 10 pounds—often becomes measurable by week 12 when you've advanced to the 1.0 mg dose. Continued progression through higher doses generally produces cumulative results, with peak effects observed once you reach the 2.4 mg maintenance dose and maintain it for several months.

The timeline varies significantly between individuals based on starting weight, diet, exercise habits, and genetic factors influencing GLP-1 receptor sensitivity. Some patients experience steady progress every four weeks, while others see plateaus followed by accelerated loss as their dose increases. PlexusDx offers genetic testing through the Precision Peptide Genetic Test to identify your peptide-pathway predispositions, revealing whether variants in your GLP1R gene may affect how responsively you'll lose weight on semaglutide.

Expected Weight Loss at Each Semaglutide Dose Level

At the starting 0.25 mg dose, weight loss is typically modest—often 2 to 3 pounds over the first month—because the appetite-suppressing effect is mild. By the time you reach 0.5 mg in week 4, most patients report noticeably reduced hunger and may lose 3 to 5 pounds that month. The 1.0 mg dose, reached by week 8, tends to trigger more substantial appetite suppression, with many patients experiencing 5 to 8 pounds of monthly loss.

Higher maintenance doses of 1.7 mg and 2.4 mg generally produce the most significant results, with average monthly losses of 6 to 10 pounds sustained over several months as your body adjusts to the medication. However, weight loss is not linear—some weeks show rapid progress while others plateau, which is a normal biological response. Research shows that cumulative weight loss over 12 to 16 months of consistent semaglutide use ranges from 15% to 22% of starting body weight in clinical trials, though individual outcomes depend on adherence, lifestyle, and genetic metabolism factors.

Cost and Access: Affordable Semaglutide Without Insurance

PlexusDx provides compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan through licensed 503A compounding pharmacies, offering a transparent flat-rate pricing structure regardless of which dose level you're currently taking. Your dose may increase throughout your treatment plan, but your monthly investment stays the same—a model designed to remove financial barriers to reaching therapeutic dosing. The medication is available to all 50 states without insurance requirements, membership fees, or surprise pricing changes.

All PlexusDx semaglutide compounds are prepared in licensed 503A pharmacies using high-purity pharmaceutical ingredients and sterile techniques that meet FDA standards for compounding. Coverage through HSA and FSA accounts is available, allowing you to use pre-tax healthcare dollars to reduce out-of-pocket costs. PlexusDx also offers the optional Precision Peptide Genetic Test for $298, providing personalized insights into your GLP-1 receptor genetics and peptide-pathway predispositions to optimize your treatment strategy.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How many semaglutide injections do I need to take before seeing weight loss results?

Most patients notice appetite suppression and early weight loss between their second and fourth injections (weeks 4 to 8) as their dose climbs to 0.5 to 1.0 mg. Significant, sustained weight loss typically becomes evident after 12 weeks of consistent weekly injections once you've reached higher dose levels. PlexusDx patients begin their treatment with a clear dosing calendar and support to track progress at each phase.

What clinical evidence supports semaglutide for weight loss?

The landmark STEP trials published in The New England Journal of Medicine demonstrated that semaglutide at 2.4 mg weekly produced average weight loss of 15.3% over 68 weeks, compared to 2.6% with placebo. Additional research shows sustained weight loss maintenance when patients continue treatment, with metabolic benefits including improved blood sugar control and cardiovascular markers. These results form the evidence base for semaglutide's FDA approval as a weight-loss medication and its widespread clinical use.

Can I use my HSA or FSA to pay for PlexusDx semaglutide?

Yes, PlexusDx semaglutide injections qualify for HSA and FSA payment, allowing you to use pre-tax healthcare savings to cover your monthly prescription at $189/mo month-to-month, or from $149/mo on the 6-month plan. This benefit applies to all tiers and dose adjustments without additional enrollment steps. Simply provide your HSA or FSA card information during checkout for immediate eligible-expense coverage.

Are there safety concerns with weekly semaglutide injections?

The most common side effects are gastrointestinal—nausea, vomiting, and constipation—which typically occur early in treatment and diminish as your body adapts over weeks. Serious adverse events are rare and usually occur when semaglutide is used inappropriately or in undisclosed combinations. PlexusDx requires a consultation with a licensed healthcare provider before dispensing to ensure semaglutide is appropriate for your medical history and current medications.

How does the PlexusDx Precision Peptide Genetic Test help with semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Losing Weight
• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.